Invention Grant
- Patent Title: Kinase inhibitors
-
Application No.: US12380493Application Date: 2009-02-26
-
Publication No.: US08455656B2Publication Date: 2013-06-04
- Inventor: Lon T. Spada , Jane Guo Shiah , Patrick Hughes , Thomas C. Malone , Gerald W. Devries , Jeffrey L. Edelman , Julie A. Wurster , Xialing Guo , Sougato Boral
- Applicant: Lon T. Spada , Jane Guo Shiah , Patrick Hughes , Thomas C. Malone , Gerald W. Devries , Jeffrey L. Edelman , Julie A. Wurster , Xialing Guo , Sougato Boral
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Laura L. Wine; Joel B. German; Debra D. Condino
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61F9/007 ; C07D213/00
Abstract:
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.
Public/Granted literature
- US20120238558A9 Kinase inhibitors Public/Granted day:2012-09-20
Information query
